Prosecution Insights
Last updated: November 20, 2026
Application No. 18/683,593

RESIN, METHOD FOR PRODUCING RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT

Non-Final OA §102§103§112
Filed
Feb 14, 2024
Priority
Aug 18, 2021 — JP 2021-133308 +1 more
Examiner
KARST, DAVID THOMAS
Art Unit
1767
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Mitsubishi Gas Chemical Company, Inc.
OA Round
1 (Non-Final)
65%
Grant Probability
Moderate
1-2
OA Rounds
2m
Est. Remaining
75%
With Interview

Examiner Intelligence

Grants 65% of resolved cases
65%
Career Allowance Rate
662 granted / 1021 resolved
At TC average
Moderate +10% lift
Without
With
+10.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
46 currently pending
Career history
1086
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
49.2%
+9.2% vs TC avg
§102
13.4%
-26.6% vs TC avg
§112
27.5%
-12.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1021 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 1-10 and 23-25, without traverse in the reply filed on 08/12/2026 is acknowledged. Claims 11-22 and 26 withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to nonelected inventions, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 8/12/2026. Priority Applicant’s claim for the benefit of a prior-filed application under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) is acknowledged. Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 25 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 25 recites the limitation "the thermosetting compound" in lines 1-2. There is insufficient antecedent basis for this limitation in the claim because claims 23 and 25 do not recite the limitation “a thermosetting compound”. Since claim 24 recites the limitation “a thermosetting compound” in lines 1-2, for further examination of the claims, claim 25 is interpreted as depending from claim 24. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-4, 7, 8, and 10 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Wakita et al. (JP 2020-037651 A, cited in IDS, machine translation in English used for citation, made of record on 07/16/2026). Regarding claims 1, 3, and 10, Wakita teaches a (meth)acrylate resin obtained by esterifying a phenol-modified aromatic hydrocarbon formaldehyde resin with (meth)acrylic acid halide [0008, 0012], wherein the phenol-modified aromatic hydrocarbon formaldehyde resin is an aromatic hydrocarbon formaldehyde resin that has been modified with phenols [0008, 0026], wherein the aromatic hydrocarbon formaldehyde resin is obtained by reacting an aromatic hydrocarbon with formaldehyde [0027], wherein the aromatic hydrocarbon is at least one selected from benzene, toluene, xylene, mesitylene, ethylbenzene, and propylbenzene [0027], wherein the phenols are at least one selected from phenol, cresol, xylenol, butylphenol, octylphenol, and nonylphenol [0029], which reads on a resin having constituent units described in Group (1) wherein R1’s each independently represent a methylene group, R2 represents an alkyl group having 1 to 3 carbon atoms, R3, R4, and R5 each independently represent an alkyl group having 1, 4, 8, or 9 carbon atoms, R6 independently represents a hydrogen atom or an alkyl group having 1 carbon atom, R7 and R8 each independently represent a hydrogen atom, R9 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 10 carbon atoms, a hydroxy group, a hydroxyalkyl group having 1 to 10 carbon atoms, or an aryl group having 6 to 12 carbon atoms, v represents 1, w represents a number of 1 to 3, and x, y, and z each independently represent a number of 0 to 2, a, b, c, and d each independently represent a molar ratio of the constituent unit, wherein a is a number of 1 or more, b is a number of 0 or more, c is a number of 1 or more, and d is a number of 0, R1s may be bonded to each other to form a crosslinked structure, and * represents a position of bonding to another constituent or an end group as claimed, wherein in Group (1), R3, R4, and R5 are each independently an alkyl group having 1, 4, 8, or 9 carbon atoms as claimed, wherein an end group of the resin is selected from a hydrogen atom and a hydroxyl group as claimed. Regarding claim 2, Wakita teaches a (meth)acrylate resin obtained by esterifying a phenol-modified aromatic hydrocarbon formaldehyde resin with (meth)acrylic acid halide [0008, 0012], wherein the phenol-modified aromatic hydrocarbon formaldehyde resin is an aromatic hydrocarbon formaldehyde resin that has been modified with phenols [0008, 0026], wherein the phenols are at least one selected from phenol, cresol, xylenol, butylphenol, octylphenol, and nonylphenol [0029], which reads on a specific embodiment wherein the (meth)acrylate resin is a methacrylate resin, and the (meth)acrylic acid halide is methacrylic acid halide, which reads on wherein in Group (1), R6 is a methyl group, and R7 and R8 are hydrogen atoms. Regarding claim 4, Wakita teaches that the phenols are at least one selected from phenol, cresol, xylenol, and butylphenol [0029], which reads on wherein in Group (1), R3, R4, and R5 are each independently an alkyl group having 1 or 4 carbon atoms as claimed. Regarding claims 7 and 8, Wakita teaches a (meth)acrylate resin obtained by esterifying a phenol-modified aromatic hydrocarbon formaldehyde resin with (meth)acrylic acid halide [0008, 0012], wherein the phenol-modified aromatic hydrocarbon formaldehyde resin is an aromatic hydrocarbon formaldehyde resin that has been modified with phenols [0008, 0026], wherein the aromatic hydrocarbon formaldehyde resin is obtained by reacting an aromatic hydrocarbon with formaldehyde [0027], wherein the aromatic hydrocarbon is mesitylene [0027], wherein the phenols are at least one selected from phenol, cresol, xylenol, butylphenol, octylphenol, and nonylphenol [0029], which reads on wherein the constituent units described in Group (1) comprise at least one selected from constituent units described in Group (1-4), wherein R1, R3, R4, R5, R6, R7, R8, R9, v, x, y, z, a4, b, c, and d are as defined for R1, R3, R4, R5, R6, R7, R8, R9, v, x, y, z, a, b, c, and d in Group (1), respectively, and * represents a position of bonding to another constituent unit or an end group as claimed, wherein the constituent units described in Group (1) comprise constituent units described in Group (1-4). Claim 23 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Wakita et al. (JP 2020-037651 A, cited in IDS, machine translation in English used for citation, made of record on 07/16/2026). Regarding claim 23, Wakita teaches a curable resin composition comprising a (meth)acrylate resin [0008, 0036], wherein the (meth)acrylate resin is obtained by esterifying a phenol-modified aromatic hydrocarbon formaldehyde resin with (meth)acrylic acid halide [0008, 0012], wherein the phenol-modified aromatic hydrocarbon formaldehyde resin is an aromatic hydrocarbon formaldehyde resin that has been modified with phenols [0008, 0026], wherein the aromatic hydrocarbon formaldehyde resin is obtained by reacting an aromatic hydrocarbon with formaldehyde [0027], wherein the aromatic hydrocarbon is at least one selected from benzene, toluene, xylene, mesitylene, ethylbenzene, and propylbenzene [0027], wherein the phenols are at least one selected from phenol, cresol, xylenol, butylphenol, octylphenol, and nonylphenol [0029], which reads on a curable resin composition comprising a resin having constituent units described in Group (1) wherein R1s each independently represent a methylene group, R2 represents an alkyl group having 1 to 3 carbon atoms, R3, R4, and R5 each independently represents an alkyl group having 1, 4, 8, or 9 carbon atoms, R6 independently represents a hydrogen atom or an alkyl group having 1 carbon atom, R7 and R8 each independently represent a hydrogen atom, R9 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 10 carbon atoms, a hydroxy group, a hydroxyalkyl group having 1 to 10 carbon atoms, or an aryl group having 6 to 12 carbon atoms, v represents 1, w represents a number of 1 to 3, and x, y, and z each independently represent a number of 0 to 2, a, b, c, or d independently represent a molar ratio of the constituent unit, where a is a number of 1 or more, b is a number of 0 or more, c is a number of 1 or more, and d is a number of 0, R1s may be bonded to each other to form a crosslinked structure, and * represents a position of bonding to another constituent unit or an end group as claimed. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 5, 6, and 9 are rejected under 35 U.S.C. 103 as being unpatentable over Wakita et al. (JP 2020-037651 A, cited in IDS, machine translation in English used for citation, made of record on 07/16/2026) as applied to claim 1. Regarding claim 5, Wakita teaches the resin according to claim 1 as explained above. Wakita teaches that the (meth)acrylate resin has a hydroxyl value of 100 mg KOH/g or less [0008, 0015], more preferably 90 mg KOH/g or less, and even more preferably 5 to 90 mg KOH/g, from the viewpoint of UV curability [0015], and that the phenolic hydroxyl value of the (meth)acrylate resin is preferably 100 mg KOH/g or less [0008, 0016], more preferably 90 mg KOH/g or less, and even more preferably 5 to 90 mg KOH/g, from the viewpoint of UV curability [0016], which reads on the resin according to claim 1, having a phenolic hydroxyl group content of 1.78 mmol/g or less. The phenolic hydroxyl group content is based on the calculation 100 mg KOH/g / (56.105 mg KOH/mmol KOH) = 1.78 mmol/g. Wakita does not teach with sufficient specificity that the resin according to claim 1 has a phenolic hydroxyl group content of 0.5 mmol/g or less. Before the effective filing date of the claimed invention, one of ordinary skill in the art would have found it obvious to optimize the phenolic hydroxyl value of Wakita’s (meth)acrylate resin to be 28 mg KOH/g or less. The proposed modification would read on the resin according to claim 1, having a phenolic hydroxyl group content of 0.5 mmol/g or less as claimed. The phenolic hydroxyl group content is based on the calculation 28 mg KOH/g / (56.105 mg KOH/mmol KOH) = 0.5 mmol/g. One of ordinary skill in the art would have been motivated to do so because it would have been beneficial for optimizing UV curability of Wakita’s (meth)acrylate resin because Wakita teaches that the (meth)acrylate resin has a hydroxyl value of 100 mg KOH/g or less [0008, 0015], more preferably 90 mg KOH/g or less, and even more preferably 5 to 90 mg KOH/g, from the viewpoint of UV curability [0015], and that the phenolic hydroxyl value of the (meth)acrylate resin is preferably 100 mg KOH/g or less [0008], more preferably 90 mg KOH/g or less, and even more preferably 5 to 90 mg KOH/g, from the viewpoint of UV curability [0008, 0016], which means that the phenolic hydroxyl value of Wakita’s (meth)acrylate resin in mg KOH/g would have affected UV curability of Wakita’s (meth)acrylate resin. Regarding claim 6, Wakita teaches the resin according to claim 1 as explained above. Wakita teaches that the (meth)acrylate resin is obtained by esterifying a phenol-modified aromatic hydrocarbon formaldehyde resin with (meth)acrylic acid halide [0008, 0012], wherein the phenol-modified aromatic hydrocarbon formaldehyde resin is an aromatic hydrocarbon formaldehyde resin that has been modified with phenols [0008, 0026], wherein the aromatic hydrocarbon formaldehyde resin is obtained by reacting an aromatic hydrocarbon with formaldehyde [0027], wherein the (meth)acrylate resin has a hydroxyl value of 100 mg KOH/g or less [0008, 0015], more preferably 90 mg KOH/g or less, and even more preferably 5 to 90 mg KOH/g, from the viewpoint of UV curability [0015], wherein the phenolic hydroxyl value of the (meth)acrylate resin is preferably 100 mg KOH/g or less [0008, 0016], more preferably 90 mg KOH/g or less, and even more preferably 5 to 90 mg KOH/g, from the viewpoint of UV curability [0016], wherein the hydroxyl value of the phenol-modified aromatic hydrocarbon formaldehyde resin is 100 to 550 mg KOH/g [0008, 0034], more preferably 100 to 500 mg KOH/g, and even more preferably 150 to 450 mg KOH/g, from the viewpoint of curability after esterification [0034], wherein the phenolic hydroxyl value of the phenol-modified aromatic hydrocarbon formaldehyde resin is 100 to 550 mg KOH/g [0008, 0035], more preferably 100 to 500 mg KOH/g, and even more preferably 150 to 450 mg KOH/g, from the viewpoint of curability after esterification [0035], which reads on the resin according to claim 1, having a content of a group represented by the following in Group (I) of more than 0 mmol/g: PNG media_image1.png 86 96 media_image1.png Greyscale wherein R6 to R8 are as defined for R6 to R8 in Group (1). Wakita does not teach that the resin according to claim 1 has a content of a group represented by the following in Group (1) of 1.0 mmol/g or more: PNG media_image1.png 86 96 media_image1.png Greyscale wherein R6 to R8 are as defined for R6 to R8 in Group (1). Before the effective filing date of the claimed invention, one of ordinary skill in the art would have found it obvious to optimize an extent of esterification of Wakita’s phenol-modified aromatic hydrocarbon formaldehyde resin with Wakita’s (meth)acrylic acid halide to be such that there are 1.0 mmol or more of (meth)acryloyloxy groups per g of Wakita’s (meth)acrylate resin that is obtained by the esterification. The proposed modification would read on the resin according to claim 1 having a content of a group represented by the following in Group (1) of 1.0 mmol/g or more: PNG media_image1.png 86 96 media_image1.png Greyscale wherein R6 to R8 are as defined for R6 to R8 in Group (1) as claimed. One of ordinary skill in the art would have been motivated to do so because it would have been beneficial for optimizing curability and UV curability of Wakita’s (meth)acrylate resin because Wakita teaches that the (meth)acrylate resin is obtained by esterifying a phenol-modified aromatic hydrocarbon formaldehyde resin with (meth)acrylic acid halide [0008, 0012], wherein the phenol-modified aromatic hydrocarbon formaldehyde resin is an aromatic hydrocarbon formaldehyde resin that has been modified with phenols [0008, 0026], wherein the aromatic hydrocarbon formaldehyde resin is obtained by reacting an aromatic hydrocarbon with formaldehyde [0027], wherein the (meth)acrylate resin has a hydroxyl value of 100 mg KOH/g or less [0008, 0015], more preferably 90 mg KOH/g or less, and even more preferably 5 to 90 mg KOH/g, from the viewpoint of UV curability [0015], wherein the phenolic hydroxyl value of the (meth)acrylate resin is preferably 100 mg KOH/g or less [0008, 0016], more preferably 90 mg KOH/g or less, and even more preferably 5 to 90 mg KOH/g, from the viewpoint of UV curability [0016], wherein the hydroxyl value of the phenol-modified aromatic hydrocarbon formaldehyde resin is 100 to 550 mg KOH/g [0008, 0034], more preferably 100 to 500 mg KOH/g, and even more preferably 150 to 450 mg KOH/g, from the viewpoint of curability after esterification [0034], wherein the phenolic hydroxyl value of the phenol-modified aromatic hydrocarbon formaldehyde resin is 100 to 550 mg KOH/g [0008, 0035], more preferably 100 to 500 mg KOH/g, and even more preferably 150 to 450 mg KOH/g, from the viewpoint of curability after esterification [0035], which means that an extent of esterification of Wakita’s phenol-modified aromatic hydrocarbon formaldehyde resin with Wakita’s (meth)acrylic acid halide in mmol of (meth)acryloyloxy groups per g of Wakita’s (meth)acrylate resin that is obtained by the esterification would have affected curability and UV curability of Wakita’s (meth)acrylate resin. Regarding claim 9, Wakita teaches the resin according to claim 1 as explained above. Wakita teaches that the (meth)acrylate resin has a weight-average molecular weight (Mw) of 300 to 10,000 [0008, 0014], more preferably 300 to 8,000, and even more preferably 500 to 7,000, in terms of polystyrene, from the viewpoint of improving adhesion [0014], which reads on the resin according to claim 1, having a number average molecular weight (Mn) of greater than 0, and a weight average molecular weight (Mw) of 300 to 10000. Wakita does not teach that the resin according to claim 1 has a number average molecular weight (Mn) of 500 to 6000. Before the effective filing date of the claimed invention, one of ordinary skill in the art would have found it obvious to optimize the number-average molecular weight (Mn) of Wakita’s (meth)acrylate resin to be 500 to 6,000 and to optimize the weight-average molecular weight (Mw) of Wakita’s (meth)acrylate resin to be 500 to 10,000. The proposed modification would read on the resin according to claim 1 having a number average molecular weight (Mn) of 500 to 6000, and a weight average molecular weight (Mw) of 500 to 10000 as claimed. One of ordinary skill in the art would have been motivated to do so because it would have been beneficial for optimizing adhesion of Wakita’s (meth)acrylate resin because Wakita teaches that the (meth)acrylate resin has a weight-average molecular weight (Mw) of 300 to 10,000 [0008, 0014], more preferably 300 to 8,000, and even more preferably 500 to 7,000, in terms of polystyrene, from the viewpoint of improving adhesion [0014], which means that the number-average molecular weight (Mn) of Wakita’s (meth)acrylate resin and the weight-average molecular weight (Mw) of Wakita’s (meth)acrylate resin would have affected adhesion of Wakita’s (meth)acrylate resin. Claims 24 and 25 are rejected under 35 U.S.C. 103 as being unpatentable over Wakita et al. (JP 2020-037651 A, cited in IDS, machine translation in English used for citation, made of record on 07/16/2026) as applied to claim 23. Regarding claim 24, Wakita teaches the curable resin composition according to claim 23 as explained above. Wakita teaches that the composition may include epoxy resins [0036], and that the (meth)acrylate resin can be used as an additive to resins or modifier to epoxy resin [0052], which optionally reads on the curable resin composition according to claim 23, further comprising a thermosetting compound other than a resin having constituent units described in Group (1): wherein R1s each independently represent a methylene group, R2 represents an alkyl group having 1 to 3 carbon atoms, R3, R4, and R5 each independently represents an alkyl group having 1, 4, 8, or 9 carbon atoms, R6 independently represents a hydrogen atom or an alkyl group having 1 carbon atom, R7 and R8 each independently represent a hydrogen atom, R9 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 10 carbon atoms, a hydroxy group, a hydroxyalkyl group having 1 to 10 carbon atoms, or an aryl group having 6 to 12 carbon atoms, v represents 1, w represents a number of 1 to 3, and x, y, and z each independently represent a number of 0 to 2, a, b, c, or d independently represent a molar ratio of the constituent unit, where a is a number of 1 or more, b is a number of 0 or more, c is a number of 1 or more, and d is a number of 0, R1s may be bonded to each other to form a crosslinked structure, and * represents a position of bonding to another constituent unit or an end group. Wakita does not teach a specific embodiment of the curable resin composition according to claim 23 further comprising a thermosetting compound other than a resin having constituent units described in Group (1). Before the effective filing date of the claimed invention, one of ordinary skill in the art would have found it obvious to use Wakita’s epoxy resin to modify Wakita’s curable resin composition. The proposed modification would read on of the curable resin composition according to claim 23 further comprising a thermosetting compound other than a resin having constituent units described in Group (1) as claimed. One of ordinary skill in the art would have been motivated to do so because Wakita teaches that the composition may include epoxy resins [0036], and that when the (meth)acrylate resin is used as an additive to resins and modifier for epoxy resin, the water resistance, chemical resistance, and heat resistance of these resins can be improved [0052]. Regarding claim 25, Wakita teaches the curable resin composition according to claim 23 as explained above. Wakita teaches that the (meth)acrylate resin can be used as an additive to resins or modifier for vinyl ester resin or unsaturated polyester resin [0052], wherein the vinyl ester resins are resin obtained by adding epoxy groups and approximately equivalent moles of α,β-unsaturated monobasic acid to polyepoxide in the presence of an addition catalyst, and mixing the reaction product with a polymerizable monomer, and adding polymerization inhibitors as needed [0055], wherein the unsaturated polyester resins are resins obtained by reacting an unsaturated polyester, which is obtained by reacting an acid that is an unsaturated dibasic acid with an alcohol, with a polymerizable monomer, and adding polymerization inhibitors as needed [0058], which optionally reads on the curable resin composition according to claim 23, wherein the thermosetting compound comprises at least one selected from the group consisting of a compound having a carbon-carbon unsaturated bond group other than a resin having constituent units described in Group (1): wherein R1s each independently represent a methylene group, R2 represents an alkyl group having 1 to 3 carbon atoms, R3, R4, and R5 each independently represents an alkyl group having 1, 4, 8, or 9 carbon atoms, R6 independently represents a hydrogen atom or an alkyl group having 1 carbon atom, R7 and R8 each independently represent a hydrogen atom, R9 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 10 carbon atoms, a hydroxy group, a hydroxyalkyl group having 1 to 10 carbon atoms, or an aryl group having 6 to 12 carbon atoms, v represents 1, w represents a number of 1 to 3, and x, y, and z each independently represent a number of 0 to 2, a, b, c, or d independently represent a molar ratio of the constituent unit, where a is a number of 1 or more, b is a number of 0 or more, c is a number of 1 or more, and d is a number of 0, R1s may be bonded to each other to form a crosslinked structure, and * represents a position of bonding to another constituent unit or an end group. Wakita does not teach a specific embodiment of the curable resin composition according to claim 23, wherein the thermosetting compound comprises at least one selected from the group consisting of a compound having a carbon-carbon unsaturated bond group other than a resin having constituent units described in Group (1). Before the effective filing date of the claimed invention, one of ordinary skill in the art would have found it obvious to use Wakita’s vinyl ester resin or unsaturated polyester resin to modify Wakita’s curable resin composition. The proposed modification would read on the curable resin composition according to claim 23, wherein the thermosetting compound comprises at least one selected from the group consisting of a compound having a carbon-carbon unsaturated bond group other than a resin having constituent units described in Group (1) as claimed. One of ordinary skill in the art would have been motivated to do so because Wakita teaches that when the (meth)acrylate resin is used as an additive to resins and modifier for vinyl esters and unsaturated polyester, the water resistance, chemical resistance, and heat resistance of these resins can be improved [0052]. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to DAVID KARST whose telephone number is (571)270-7732. The examiner can normally be reached Monday-Friday 8:00 AM-5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark Eashoo can be reached at 571-272-1197. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DAVID T KARST/Primary Examiner, Art Unit 1767
Read full office action

Prosecution Timeline

Feb 14, 2024
Application Filed
Oct 27, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12799289
RESIN COMPOSITION, PREPREG OBTAINED USING SAME, RESIN-COATED FILM, RESIN-COATED METAL FOIL, METAL-CLAD LAMINATE, AND WIRING BOARD
4y 8m to grant Granted Nov 17, 2026
Patent 12799271
POLYESTER MOLDED BODY AND METHOD FOR MANUFACTURING SAME
3y 9m to grant Granted Nov 17, 2026
Patent 12799272
THERMOPLASTIC POLYESTER ELASTOMER, RESIN COMPOSITION CONTAINING SUCH ELASTOMER, AND MOLDED ARTICLE OBTAINED FROM THE RESIN COMPOSITION
3y 2m to grant Granted Nov 17, 2026
Patent 12799375
ELECTROMAGNETIC CURABLE NOVEL TOUGHENED EPOXY-HYBRID STRUCTURAL ADHESIVES AND APPLICATIONS USING THE SAME
2y 1m to grant Granted Nov 17, 2026
Patent 12781024
FLAME RETARDANT COMPOSITION, PREPREG, AND FIBER REINFORCED COMPOSITE MATERIAL
4y 7m to grant Granted Nov 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
75%
With Interview (+10.0%)
2y 11m (~2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1021 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month